Data / Form D filings / Vitls Inc.
Vitls Inc.: Form D filings
Vitls Inc., a biotechnology company in Houston, TX, filed 4 Form D notices with the SEC between 2018 and 2022. The latest, on November 29, 2022, reports $1.3 million sold of a $2 million offering to 9 investors.
Find out what Vitls Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 HOLCOMBE BLVD., SUITE X+210, C/O TMCX MED CENTRE INNOVATION INSTITUTE, Houston, TX, 77021
- Phone
- (415) 949-9963
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1749947
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | New notice | $2,000,000 | $1,311,301 | $688,699 | 9 | Nov 14, 2022 | sec.gov |
| Nov 12, 2021 | New notice | $5,335,212 | $4,475,212 | $860,000 | 24 | Oct 28, 2021 | sec.gov |
| Dec 18, 2018 | New notice | $385,000 | $385,000 | $0 | 7 | May 10, 2017 | sec.gov |
| Aug 13, 2018 | New notice | $1,065,000 | $1,065,000 | $0 | 11 | Jul 30, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cadell Liedtke | Director | |
| Greg Moss | Director | |
| Louise Vorster | Executive Officer, Director | |
| Greg Campbell | Director | |
| Werner Vorster | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Nov 28, 2022 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vitls Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.